#34: FastFun: Hemispherx Biopharma Files New Drug Application for Ampligen as Treatment for Chronic Fatigue Syndrome
Thursday October 11, 10:00 am ET NDA of Investigational Drug Includes Four... |
October 12, 2007
01:13:09 PM |
#33: FastFun: 30 years in the making, chronic fatigue drug goes to FDA
Thursday October 11, 11:15 am ET
Hemispherx Biopharma Inc. filed a new drug... |
October 12, 2007
01:06:29 PM |
#32: NewsBot: HEB News Hemispherx Biopharma Announces 2006 Financial Results
PHILADELPHIA--(BUSINESS WIRE)--Hemispherx Biopharma, Inc. (AMEX: HEB) announced... |
March 19, 2007
02:51:00 PM |
#31: NewsBot: HEB News Hemispherx Avian Flu Prevention/Treatment Program Announces New Primate Results and Expands in both Europe and Southern Hemisphere
PHILADELPHIA--(BUSINESS WIRE)--Hemispherx Biopharma, Inc. (AMEX:HEB) announced... |
February 14, 2007
10:18:00 AM |
#30: NewsBot: HEB News Hemispherx Biopharma to Present at The Roth Capital Partners 19th OC Conference in Dana Point, California
PHILADELPHIA--(BUSINESS WIRE)--Hemispherx, Inc. (Amex: HEB), a biotechnology firm... |
January 23, 2007
05:30:00 AM |
#29: NewsBot: HEB News Hemispherx Comments on Chronic Fatigue Syndrome Initiatives by the Centers for Disease Control
PHILADELPHIA--(BUSINESS WIRE)--Hemispherx, Inc. (Amex: HEB), a biopharmaceutical... |
December 12, 2006
05:30:00 AM |
#28: NewsBot: HEB News Hemispherx Biopharma Hires New President/Chief Operating Officer to Lead the Company's Drive to Commercialization
PHILADELPHIA--(BUSINESS WIRE)--Hemispherx Biopharma, Inc. (AMEX: HEB) announced... |
November 28, 2006
05:30:00 AM |
#27: NewsBot: HEB News Hemispherx Biopharma Appoints McGladrey & Pullen as Independent Auditing Firm
PHILADELPHIA--(BUSINESS WIRE)--Hemispherx Biopharma, Inc. (AMEX: HEB) announced... |
November 9, 2006
05:30:00 AM |
#26: NewsBot: HEB News Hemispherx Biopharma Announces Third Quarter 2006 Results and Strategic Update
PHILADELPHIA--(BUSINESS WIRE)--Hemispherx Biopharma, Inc. (AMEX: HEB) announced... |
November 7, 2006
08:30:00 AM |
#25: NewsBot: HEB News Hemispherx Biopharma to Present at Rodman & Renshaw Healthcare Conference, November 6th
PHILADELPHIA--(BUSINESS WIRE)--Hemispherx Biopharma, Inc. (AMEX: HEB) announced... |
October 30, 2006
05:30:00 AM |
#24: NewsBot: HEB News Researchers at Japanese National Institute of Infectious Diseases Present New Data on Hemispherx's Vaccine Enhancement Platform
VIENNA, Austria--(BUSINESS WIRE)--Hemispherx Biopharma, Inc. (AMEX: HEB) announced... |
October 23, 2006
05:30:00 AM |
#23: NewsBot: HEB News Hemispherx Biopharma Will Present at Urchin Capital Partners ''Value Below the Radar 2006'' Investor Conference on October 24, 2006 in San Francisco
PHILADELPHIA--(BUSINESS WIRE)--Hemispherx Biopharma, Inc. (AMEX: HEB) announced... |
October 19, 2006
05:30:00 AM |
#22: NewsBot: HEB News Hemispherx Biopharma's Vaccine Enhancement Platform to be Presented at the Second International Conference on Influenza Vaccines for the World
VIENNA, Austria--(BUSINESS WIRE)--Hemispherx Biopharma, Inc. (AMEX: HEB) announced... |
October 16, 2006
05:30:00 AM |
#21: NewsBot: HEB News Hemispherx Biopharma to Present at 8th International IACFS Conference on Chronic Fatigue Syndrome, Fibromyalgia, Related Illnesses; Successful Transfer of Technology to Expand Drug Production Announced
PHILADELPHIA--(BUSINESS WIRE)--Sept. 21, 2006--Hemispherx Biopharma, Inc. (AMEX:... |
September 21, 2006
05:30:00 AM |
#20: NewsBot: HEB News Hemispherx Biopharma to Present At Fall 2006 Micro Cap Conference
PHILADELPHIA--(BUSINESS WIRE)--Sept. 18, 2006--Hemispherx Biopharma, Inc. (AMEX:... |
September 18, 2006
05:30:00 AM |
| 
| 
| 
| 
| 
| 
